Chlordiazepoxide Hydrochloride And Clidinium Bromide Capsule
Product Images NDC 11534-197

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride And Clidinium Bromide (NDC 11534-197). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sunrise Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 100

This is a medication called Chlordiazepoxide HCI and Clidinium Bromide Capsules, USP. Each capsule contains 5mg of Chlordiazepoxide HCI and 25mg of Clidintum Bromude. These capsules are suggested to take one or two capsules 3 or 4 times a day. This medication guide should be provided to each patient by the pharmacist. These capsules should be kept out of reach of children and stored at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F). This medication should be dispensed in a tight, light-resistant container. The manufacturer of this medication is Sunrise Pharmaceutical, Inc. with Rev. 02/2019 production date.*

FDA Label Image

Structure Chlordiazepoxide

FDA Label Image

Structure Clidinium

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.